• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Advertisement

New Delhi Feb. 13 Japanese automobile company Toyota today indicated that it would consider launching the eco-friendly car Prius in India if the current duty on completely built units (CBUs) was reduced.

The current duty structure on CBUs would double the price of the vehicle.

"We are studying the Indian market to introduce our hybrid vehicle here.

It would be brought here as a CBU, but at current levels of duty it could cost anywhere between Rs 20-25 lakh,'' the Toyota Kirloskar Managing Director, Mr A. Toyoshima, said while speaking to presspersons on the sidelines of the International Engineering & Technology Fair (IETF) here.

Toyota sells Prius for about Rs 10 lakh in the US and the company claims the model accounts for nearly 80 per cent of the hybrid vehicle sales globally.

Relax duty structure

He said the Indian Government should relax the duty structure for such hybrid vehicles to promote eco-friendly technology in the country.

When asked about the company's plans of setting up a small car manufacturing facility in India, Mr Toyoshima said, ``We are still studying the fine details for setting up a small car plant in India and it will take some time before we decide anything.''

Meanwhile, Honda Motor Company today unveiled the company's latest technological innovations in producing environment-friendly fuels and advanced mobility at the IETF.

Honda displayed its latest generation fuel-cell car, the "FCX Concept".

More Stories on : Outlook | Cars

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Bharat Bio to do clinical trials for JE vaccine

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line